Lasiodin

CAS No. 28957-08-6

Lasiodin( Lasiokaurin )

Catalog No. M29178 CAS No. 28957-08-6

Lasiodin has anti-oxidative, and antineoplastic activities, it also shows antibacterial activity, esp. against Sarcina lutea.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 414 Get Quote
10MG 608 Get Quote
25MG 954 Get Quote
50MG 1287 Get Quote
100MG 1737 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Lasiodin
  • Note
    Research use only, not for human use.
  • Brief Description
    Lasiodin has anti-oxidative, and antineoplastic activities, it also shows antibacterial activity, esp. against Sarcina lutea.
  • Description
    Lasiodin has anti-oxidative, and antineoplastic activities, it also shows antibacterial activity, esp. against Sarcina lutea.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Lasiokaurin
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    P450
  • Recptor
    P450
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    28957-08-6
  • Formula Weight
    406.475
  • Molecular Formula
    C22H30O7
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    [H][C@@]12CC[C@@H]3[C@@H](O)[C@]1(C(=O)C3=C)[C@@]1(O)OC[C@]22[C@H](CCC(C)(C)[C@@]2([H])[C@@H]1O)OC(C)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Dihydromethysticin

    Dihydromethysticin is a kavalactone found in Piper methysticum.

  • DMU2105

    DMU2105 is a specific CYP1B1 inhibitor(CYP1B1 and CYP1A1 with IC50 of 10 nM and 742 nM, respectively)

  • N-Nornuciferine hydr...

    N-Nornuciferine is an aporphine alkaloid in lotus leaf, significantly inhibits CYP2D6 (IC50: 3.76 μM, Ki: 2.34 μM).N-Nornuciferine strongly inhibits CYP2D6 activity but shows weak or no inhibition of the other four P450 isoenzymes (CYP2C19, CYP3A4, CYP2E1, CYP2C9). N-Nornuciferine competitively inhibits the CYP2D6-catalyzed dextromethorphan O-demethylation (Ki: 2.34 μM).